Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of recurrence.
Vous n'êtes pas connecté
Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of recurrence.
Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of recurrence.
Radiotherapy, particularly stereotactic ablative radiotherapy (SABR), is widely used for treating cancers in the lung, liver, prostate, and other...
Mr Samuel Atidzah, Executive Director of GOSANET Foundation says despite significant progress made in Tuberculosis (TB) prevention and treatment, many...
GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product...
Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research...
Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research...
A new editorial was published in Oncotarget, Volume 16, on March 13, 2025, titled "No disease left behind."
FRIDAY, March 21, 2025 -- A blood test used to check for ovarian cancer may not work as well for Black and Native American women, a new study...
FRIDAY, March 21, 2025 -- A blood test used to check for ovarian cancer may not work as well for Black and Native American women, a new study...
WEDNESDAY, March 26, 2025 -- Urine glycosaminoglycan profiles (GAGomes) have high sensitivity for nonmetastatic clear-cell renal cell carcinoma...